A German newspaper, Boersen-Zeitung, mentioned Zentiva, Stada and PlasmaSelect (generic pharmaceuticals) as the next takeover targets. The paper said that a company purchasing Zentiva would benefit from the company’s access to Central and Eastern European markets. Note that Novartis earlier bought German generic drug producer Hexal for 4xSales, valuing Zentiva’s shares at CZK1,238.